NewLink Genetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NLNK and buy or sell other stocks, ETFs, and their options commission-free!About NLNK
Lumos Pharma, Inc. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians.
CEORichard J. Hawkins
CEORichard J. Hawkins
Employees—
Employees—
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1999
Founded1999
Employees—
Employees—
NLNK Key Statistics
Market cap26.03M
Market cap26.03M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume74.85K
Average volume74.85K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.58
52 Week high$4.58
52 Week low$1.37
52 Week low$1.37
Stock Snapshot
As of today, NewLink Genetics(NLNK) shares are valued at $3.01. The company's market cap stands at 26.03M, with a P/E ratio of -1.01.
During the trading day, NewLink Genetics(NLNK) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for NewLink Genetics(NLNK) stock has reached 0, versus its average volume of 74.85K.
Over the past 52 weeks, NewLink Genetics(NLNK) stock has traded between a high of $4.58 and a low of $1.37.
Over the past 52 weeks, NewLink Genetics(NLNK) stock has traded between a high of $4.58 and a low of $1.37.